Our Advisors

Catenion draws on a variety of external experts to guide our firm, provide strategic direction, and help us continually improve our impact on clients.

We are honored to have outstanding individuals serve as our advisors:

Sir Mark Richmond

Former Head of Global Research of Glaxo–Wellcome. He served on the boards of Genentech Inc., OSI Pharmaceuticals, Targeted Genetics Corp., Ark Therapeutics Ltd., Paratek Pharmaceuticals Inc. and Sosei Co. Ltd.